UnitedHealth Group (UNH)
282.12
+0.00 (0.00%)
NYSE · Last Trade: Jul 29th, 6:25 AM EDT
Centene Corporation (NYSE:CNC), a leading healthcare enterprise specializing in managed care services for government-sponsored health programs, has transformed itself over the past four decades from a small regional player into a national powerhouse. Headquartered in St. Louis, Missouri, Centene's rise has been defined by an aggressive acquisition strategy, targeted
Via MarketMinute · July 28, 2025
U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.
Via Benzinga · July 28, 2025
UnitedHealth Says DOJ Investigating Its Medicare Billing Practicesstocktwits.com
Via Stocktwits · July 24, 2025
Media reports stated that the police have identified the gunman as 27-year-old Shane Tamura of Las Vegas, who had a "documented mental health history.”
Via Stocktwits · July 29, 2025
The company is expected to report a sharp year-over-year decline in earnings, with EPS projected to fall 38% and EBITDA down nearly 30%, according to Koyfin estimates.
Via Stocktwits · July 29, 2025
The healthcare giant's value has been in free fall this year as bad news continues to pile up.
Via The Motley Fool · July 28, 2025
Shares of UnitedHealth Group Incorporated (NYSE: UNH) are trading lower Monday as investors took a cautious stance ahead of the company's upcoming second-quarter earnings report on Tuesday July 29.
Via Benzinga · July 28, 2025
Health insurance company UnitedHealth (NYSE:UNH)
will be reporting results this Tuesday before market hours. Here’s what you need to know.
Via StockStory · July 27, 2025
Charter, Chipotle, and Fiserv led last week's large-cap declines amid earnings misses, downgrades, and cautious guidance.
Via Benzinga · July 27, 2025
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
Via Benzinga · July 26, 2025
Via The Motley Fool · July 25, 2025
On Thursday, the major averages closed on a mixed note, with a fall in weekly jobless claims and some positive earnings reports helping the S&P 500 Index and the Nasdaq Composite to hit fresh highs.
Via Stocktwits · July 25, 2025
U.S. stock futures showed mixed movements on Thursday, with the Dow Jones Industrial Average declining 0.7% to 44,693.91.
Via Benzinga · July 24, 2025
Shares of life sciences company Neogen (NASDAQ:NEOG)
jumped 3.4% in the morning session after the company announced the appointment of Mike Nassif as its new Chief Executive Officer and President.
Via StockStory · July 24, 2025
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.
Via Benzinga · July 24, 2025
UnitedHealth is cooperating with the DOJ on Medicare-related inquiries and has launched third-party reviews to ensure transparency and compliance.
Via Benzinga · July 24, 2025
New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.
Via Benzinga · July 23, 2025
The entire healthcare sector has fallen into a deeply discounted valuation, creating opportunities for investors who hunt for value and upside
Via MarketBeat · July 23, 2025
Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in 2012, Oscar Health has sought to simplify, personalize, and digitize the insurance experience, aiming to reshape a sector often
Via MarketMinute · July 23, 2025
Oscar Health has once again asserted itself as a formidable disruptor in the insurance sector, with its stock posting robust gains after the company exceeded Wall Street’s expectations. The latest quarterly results for Oscar Health (NYSE:OSCR) showcased not only improving financial fundamentals but also a growing footprint in
Via MarketMinute · July 23, 2025
Shares of lab services company Charles River Laboratories (NYSE:CRL)
jumped 7.5% in the morning session after the company announced a plasmid DNA manufacturing agreement with Elly's Team, a parent-led foundation working to find a cure for a rare genetic disorder.
Via StockStory · July 22, 2025